Global Chronic Obstructive Pulmonary Disease Drugs Market 2026-2030

Publisher TechNavio

Published Feb 11, 2026

Length 306 Pages

SKU # INF20865363

Description

Global Chronic Obstructive Pulmonary Disease Drugs Market 2026-2030

The global chronic obstructive pulmonary disease drugs market is forecasted to grow by USD 7943.3 mn during 2025-2030, accelerating at a CAGR of 6.2% during the forecast period. The report on the global chronic obstructive pulmonary disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of copd, strong pipeline and new drug approvals, growing demand for fixed-dose combinations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global chronic obstructive pulmonary disease drugs market is segmented as below:

By Product

Combination therapy
Monotherapy

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Inhalation
Oral
Injectable

By Disease Type

Chronic bronchitis
Emphysema

Geography

North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Russia
The Netherlands
Spain
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the expanding research in curative approaches as one of the prime reasons driving the global chronic obstructive pulmonary disease drugs market growth during the next few years. Also, advances in drug delivery devices and rising expansion of inhalation therapies will lead to sizable demand in the market.

The report on the global chronic obstructive pulmonary disease drugs market covers the following areas:

Global chronic obstructive pulmonary disease drugs market sizing
Global chronic obstructive pulmonary disease drugs market forecast
Global chronic obstructive pulmonary disease drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global chronic obstructive pulmonary disease drugs market vendors that include AstraZeneca Plc, Boehringer Ingelheim GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Inc., Exela Pharma Sciences LLC, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Mundipharma International Ltd., Novartis AG, Philip Morris International, SHIONOGI Co. Ltd., Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Ltd., Theravance Biopharma Inc., Vertex Pharmaceuticals Inc., Viatris Inc.. Also, the global chronic obstructive pulmonary disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Disease Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Chart on Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Chart on Overview on factors of disruption; 2.4 Impact of drivers and challenges; Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape: 3.1 Market ecosystem; Chart on Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Chart on Market characteristics analysis; 3.3 Value chain analysis; Chart on Value chain analysis
4 Market Sizing: 4.1 Market definition; Data Table on Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2025; 4.4 Market outlook: Forecast for 2025-2030; Chart on Global - Market size and forecast 2025-2030 ($ million); Data Table on Global - Market size and forecast 2025-2030 ($ million); Chart on Global Market: Year-over-year growth 2025-2030 (%); Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size: 5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 - 2024; Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 - 2024 ($ million); 5.2 Product segment analysis 2020 - 2024; Historic Market Size - Product Segment 2020 - 2024 ($ million); 5.3 Distribution Channel segment analysis 2020 - 2024; Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million); 5.4 Route of Administration segment analysis 2020 - 2024; Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million); 5.5 Disease Type segment analysis 2020 - 2024; Historic Market Size - Disease Type Segment 2020 - 2024 ($ million); 5.6 Geography segment analysis 2020 - 2024; Historic Market Size - Geography Segment 2020 - 2024 ($ million); 5.7 Country segment analysis 2020 - 2024; Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis: 6.1 AI Impact on Global Chronic Obstructive Pulmonary Disease Drugs Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2025 and 2030; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2025 and 2030; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2025 and 2030; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2025 and 2030; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2025 and 2030; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2025 and 2030; 7.7 Market condition; Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2025-2030 (%); Data Table on Product - Market share 2025-2030 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Combination therapy - Market size and forecast 2025-2030; Chart on Combination therapy - Market size and forecast 2025-2030 ($ million); Data Table on Combination therapy - Market size and forecast 2025-2030 ($ million); Chart on Combination therapy - Year-over-year growth 2025-2030 (%); Data Table on Combination therapy - Year-over-year growth 2025-2030 (%); 8.4 Monotherapy - Market size and forecast 2025-2030; Chart on Monotherapy - Market size and forecast 2025-2030 ($ million); Data Table on Monotherapy - Market size and forecast 2025-2030 ($ million); Chart on Monotherapy - Year-over-year growth 2025-2030 (%); Data Table on Monotherapy - Year-over-year growth 2025-2030 (%); 8.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2025-2030 (%); Data Table on Distribution Channel - Market share 2025-2030 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Hospital pharmacies - Market size and forecast 2025-2030; Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million); Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million); Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%); Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%); 9.4 Retail pharmacies - Market size and forecast 2025-2030; Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million); Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million); Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%); Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%); 9.5 Online pharmacies - Market size and forecast 2025-2030; Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million); Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million); Chart on Online pharmacies - Year-over-year growth 2025-2030 (%); Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%); 9.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration: 10.1 Market segments; Chart on Route of Administration - Market share 2025-2030 (%); Data Table on Route of Administration - Market share 2025-2030 (%); 10.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 10.3 Inhalation - Market size and forecast 2025-2030; Chart on Inhalation - Market size and forecast 2025-2030 ($ million); Data Table on Inhalation - Market size and forecast 2025-2030 ($ million); Chart on Inhalation - Year-over-year growth 2025-2030 (%); Data Table on Inhalation - Year-over-year growth 2025-2030 (%); 10.4 Oral - Market size and forecast 2025-2030; Chart on Oral - Market size and forecast 2025-2030 ($ million); Data Table on Oral - Market size and forecast 2025-2030 ($ million); Chart on Oral - Year-over-year growth 2025-2030 (%); Data Table on Oral - Year-over-year growth 2025-2030 (%); 10.5 Injectable - Market size and forecast 2025-2030; Chart on Injectable - Market size and forecast 2025-2030 ($ million); Data Table on Injectable - Market size and forecast 2025-2030 ($ million); Chart on Injectable - Year-over-year growth 2025-2030 (%); Data Table on Injectable - Year-over-year growth 2025-2030 (%); 10.6 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Disease Type: 11.1 Market segments; Chart on Disease Type - Market share 2025-2030 (%); Data Table on Disease Type - Market share 2025-2030 (%); 11.2 Comparison by Disease Type; Chart on Comparison by Disease Type; Data Table on Comparison by Disease Type; 11.3 Chronic bronchitis - Market size and forecast 2025-2030; Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million); Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million); Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%); Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%); 11.4 Emphysema - Market size and forecast 2025-2030; Chart on Emphysema - Market size and forecast 2025-2030 ($ million); Data Table on Emphysema - Market size and forecast 2025-2030 ($ million); Chart on Emphysema - Year-over-year growth 2025-2030 (%); Data Table on Emphysema - Year-over-year growth 2025-2030 (%); 11.5 Market opportunity by Disease Type; Market opportunity by Disease Type ($ million); Data Table on Market opportunity by Disease Type ($ million)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape: 13.1 Geographic segmentation; Chart on Market share by geography 2025-2030 (%); Data Table on Market share by geography 2025-2030 (%); 13.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 13.3 North America - Market size and forecast 2025-2030; Chart on North America - Market size and forecast 2025-2030 ($ million); Data Table on North America - Market size and forecast 2025-2030 ($ million); Chart on North America - Year-over-year growth 2025-2030 (%); Data Table on North America - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - North America; Data Table on Regional Comparison - North America; 13.3.1 US - Market size and forecast 2025-2030; Chart on US - Market size and forecast 2025-2030 ($ million); Data Table on US - Market size and forecast 2025-2030 ($ million); Chart on US - Year-over-year growth 2025-2030 (%); Data Table on US - Year-over-year growth 2025-2030 (%); 13.3.2 Canada - Market size and forecast 2025-2030; Chart on Canada - Market size and forecast 2025-2030 ($ million); Data Table on Canada - Market size and forecast 2025-2030 ($ million); Chart on Canada - Year-over-year growth 2025-2030 (%); Data Table on Canada - Year-over-year growth 2025-2030 (%); 13.3.3 Mexico - Market size and forecast 2025-2030; Chart on Mexico - Market size and forecast 2025-2030 ($ million); Data Table on Mexico - Market size and forecast 2025-2030 ($ million); Chart on Mexico - Year-over-year growth 2025-2030 (%); Data Table on Mexico - Year-over-year growth 2025-2030 (%); 13.4 Europe - Market size and forecast 2025-2030; Chart on Europe - Market size and forecast 2025-2030 ($ million); Data Table on Europe - Market size and forecast 2025-2030 ($ million); Chart on Europe - Year-over-year growth 2025-2030 (%); Data Table on Europe - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - Europe; Data Table on Regional Comparison - Europe; 13.4.1 Germany - Market size and forecast 2025-2030; Chart on Germany - Market size and forecast 2025-2030 ($ million); Data Table on Germany - Market size and forecast 2025-2030 ($ million); Chart on Germany - Year-over-year growth 2025-2030 (%); Data Table on Germany - Year-over-year growth 2025-2030 (%); 13.4.2 UK - Market size and forecast 2025-2030; Chart on UK - Market size and forecast 2025-2030 ($ million); Data Table on UK - Market size and forecast 2025-2030 ($ million); Chart on UK - Year-over-year growth 2025-2030 (%); Data Table on UK - Year-over-year growth 2025-2030 (%); 13.4.3 France - Market size and forecast 2025-2030; Chart on France - Market size and forecast 2025-2030 ($ million); Data Table on France - Market size and forecast 2025-2030 ($ million); Chart on France - Year-over-year growth 2025-2030 (%); Data Table on France - Year-over-year growth 2025-2030 (%); 13.4.4 Italy - Market size and forecast 2025-2030; Chart on Italy - Market size and forecast 2025-2030 ($ million); Data Table on Italy - Market size and forecast 2025-2030 ($ million); Chart on Italy - Year-over-year growth 2025-2030 (%); Data Table on Italy - Year-over-year growth 2025-2030 (%); 13.4.5 Russia - Market size and forecast 2025-2030; Chart on Russia - Market size and forecast 2025-2030 ($ million); Data Table on Russia - Market size and forecast 2025-2030 ($ million); Chart on Russia - Year-over-year growth 2025-2030 (%); Data Table on Russia - Year-over-year growth 2025-2030 (%); 13.4.6 The Netherlands - Market size and forecast 2025-2030; Chart on The Netherlands - Market size and forecast 2025-2030 ($ million); Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million); Chart on The Netherlands - Year-over-year growth 2025-2030 (%); Data Table on The Netherlands - Year-over-year growth 2025-2030 (%); 13.4.7 Spain - Market size and forecast 2025-2030; Chart on Spain - Market size and forecast 2025-2030 ($ million); Data Table on Spain - Market size and forecast 2025-2030 ($ million); Chart on Spain - Year-over-year growth 2025-2030 (%); Data Table on Spain - Year-over-year growth 2025-2030 (%); 13.5 Asia - Market size and forecast 2025-2030; Chart on Asia - Market size and forecast 2025-2030 ($ million); Data Table on Asia - Market size and forecast 2025-2030 ($ million); Chart on Asia - Year-over-year growth 2025-2030 (%); Data Table on Asia - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - Asia; Data Table on Regional Comparison - Asia; 13.5.1 China - Market size and forecast 2025-2030; Chart on China - Market size and forecast 2025-2030 ($ million); Data Table on China - Market size and forecast 2025-2030 ($ million); Chart on China - Year-over-year growth 2025-2030 (%); Data Table on China - Year-over-year growth 2025-2030 (%); 13.5.2 Japan - Market size and forecast 2025-2030; Chart on Japan - Market size and forecast 2025-2030 ($ million); Data Table on Japan - Market size and forecast 2025-2030 ($ million); Chart on Japan - Year-over-year growth 2025-2030 (%); Data Table on Japan - Year-over-year growth 2025-2030 (%); 13.5.3 India - Market size and forecast 2025-2030; Chart on India - Market size and forecast 2025-2030 ($ million); Data Table on India - Market size and forecast 2025-2030 ($ million); Chart on India - Year-over-year growth 2025-2030 (%); Data Table on India - Year-over-year growth 2025-2030 (%); 13.5.4 South Korea - Market size and forecast 2025-2030; Chart on South Korea - Market size and forecast 2025-2030 ($ million); Data Table on South Korea - Market size and forecast 2025-2030 ($ million); Chart on South Korea - Year-over-year growth 2025-2030 (%); Data Table on South Korea - Year-over-year growth 2025-2030 (%); 13.5.5 Indonesia - Market size and forecast 2025-2030; Chart on Indonesia - Market size and forecast 2025-2030 ($ million); Data Table on Indonesia - Market size and forecast 2025-2030 ($ million); Chart on Indonesia - Year-over-year growth 2025-2030 (%); Data Table on Indonesia - Year-over-year growth 2025-2030 (%); 13.5.6 Singapore - Market size and forecast 2025-2030; Chart on Singapore - Market size and forecast 2025-2030 ($ million); Data Table on Singapore - Market size and forecast 2025-2030 ($ million); Chart on Singapore - Year-over-year growth 2025-2030 (%); Data Table on Singapore - Year-over-year growth 2025-2030 (%); 13.5.7 Thailand - Market size and forecast 2025-2030; Chart on Thailand - Market size and forecast 2025-2030 ($ million); Data Table on Thailand - Market size and forecast 2025-2030 ($ million); Chart on Thailand - Year-over-year growth 2025-2030 (%); Data Table on Thailand - Year-over-year growth 2025-2030 (%); 13.6 Rest of World (ROW) - Market size and forecast 2025-2030; Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - Rest of World (ROW); Data Table on Regional Comparison - Rest of World (ROW); 13.6.1 Australia - Market size and forecast 2025-2030; Chart on Australia - Market size and forecast 2025-2030 ($ million); Data Table on Australia - Market size and forecast 2025-2030 ($ million); Chart on Australia - Year-over-year growth 2025-2030 (%); Data Table on Australia - Year-over-year growth 2025-2030 (%); 13.6.2 UAE - Market size and forecast 2025-2030; Chart on UAE - Market size and forecast 2025-2030 ($ million); Data Table on UAE - Market size and forecast 2025-2030 ($ million); Chart on UAE - Year-over-year growth 2025-2030 (%); Data Table on UAE - Year-over-year growth 2025-2030 (%); 13.6.3 Brazil - Market size and forecast 2025-2030; Chart on Brazil - Market size and forecast 2025-2030 ($ million); Data Table on Brazil - Market size and forecast 2025-2030 ($ million); Chart on Brazil - Year-over-year growth 2025-2030 (%); Data Table on Brazil - Year-over-year growth 2025-2030 (%); 13.6.4 South Africa - Market size and forecast 2025-2030; Chart on South Africa - Market size and forecast 2025-2030 ($ million); Data Table on South Africa - Market size and forecast 2025-2030 ($ million); Chart on South Africa - Year-over-year growth 2025-2030 (%); Data Table on South Africa - Year-over-year growth 2025-2030 (%); 13.6.5 Saudi Arabia - Market size and forecast 2025-2030; Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million); Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million); Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%); Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%); 13.6.6 Turkey - Market size and forecast 2025-2030; Chart on Turkey - Market size and forecast 2025-2030 ($ million); Data Table on Turkey - Market size and forecast 2025-2030 ($ million); Chart on Turkey - Year-over-year growth 2025-2030 (%); Data Table on Turkey - Year-over-year growth 2025-2030 (%); 13.7 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity: 14.1 Market drivers; Rising prevalence of COPD; Strong pipeline and new drug approvals; Growing demand for fixed-dose combinations; 14.2 Market challenges; Low diagnosis rates of diseases; High cost of conducting clinical trials; Obstacles to reimbursement; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2025 and 2030; 14.4 Market opportunities; Expanding research in curative approaches; Advances in drug delivery devices; Rising expansion of inhalation therapies
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 16.5 Boehringer Ingelheim GmbH; Boehringer Ingelheim GmbH - Overview; Boehringer Ingelheim GmbH - Product / Service; Boehringer Ingelheim GmbH - Key news; Boehringer Ingelheim GmbH - Key offerings; SWOT; 16.6 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; SWOT; 16.7 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; SWOT; 16.8 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 16.9 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 16.10 Innoviva Inc.; Innoviva Inc. - Overview; Innoviva Inc. - Product / Service; Innoviva Inc. - Key news; Innoviva Inc. - Key offerings; SWOT; 16.11 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 16.12 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 16.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 16.14 SHIONOGI Co. Ltd.; SHIONOGI Co. Ltd. - Overview; SHIONOGI Co. Ltd. - Product / Service; SHIONOGI Co. Ltd. - Key offerings; SWOT; 16.15 Sumitomo Pharma Co. Ltd.; Sumitomo Pharma Co. Ltd. - Overview; Sumitomo Pharma Co. Ltd. - Business segments; Sumitomo Pharma Co. Ltd. - Key offerings; Sumitomo Pharma Co. Ltd. - Segment focus; SWOT; 16.16 Teva Pharmaceutical Ltd.; Teva Pharmaceutical Ltd. - Overview; Teva Pharmaceutical Ltd. - Business segments; Teva Pharmaceutical Ltd. - Key news; Teva Pharmaceutical Ltd. - Key offerings; Teva Pharmaceutical Ltd. - Segment focus; SWOT; 16.17 Theravance Biopharma Inc.; Theravance Biopharma Inc. - Overview; Theravance Biopharma Inc. - Product / Service; Theravance Biopharma Inc. - Key offerings; SWOT; 16.18 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; SWOT
17 Appendix: 17.1 Scope of the report; Market definition; Objectives; Notes and caveats; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations

Search Inside Report

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now